Jesus G Valenzuela Selected Research

Leishmaniasis

11/2022	Immune Response to LinB13, a Lutzomyia Intermedia Salivary Protein Correlates With Disease Severity in Tegumentary Leishmaniasis.
1/2022	Some Good and Some Bad: Sand Fly Salivary Proteins in the Control of Leishmaniasis and in Autoimmunity.
12/2020	A Lutzomyia longipalpis Salivary Protein Induces Cross-Reactive Antibodies to Pemphigus Autoantigen Desmoglein 1.
10/2020	Engineering a vector-based pan-Leishmania vaccine for humans: proof of principle.
1/2020	Immunity to vector saliva is compromised by short sand fly seasons in endemic regions with temperate climates.
1/2018	Gut Microbes Egested during Bites of Infected Sand Flies Augment Severity of Leishmaniasis via Inflammasome-Derived IL-1β.
1/2018	Mosquito Saliva: The Hope for a Universal Arbovirus Vaccine?
1/2018	Immunization of Experimental Dogs With Salivary Proteins From Lutzomyia longipalpis, Using DNA and Recombinant Canarypox Virus Induces Immune Responses Consistent With Protection Against Leishmania infantum.
1/2018	Phlebotomus papatasi Yellow-Related and Apyrase Salivary Proteins Are Candidates for Vaccination against Human Cutaneous Leishmaniasis.
1/2018	Comparative Evolution of Sand Fly Salivary Protein Families and Implications for Biomarkers of Vector Exposure and Salivary Vaccine Candidates.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jesus G Valenzuela Research Topics

Disease

26	Leishmaniasis 11/2022 - 12/2004
24	Infections 11/2022 - 10/2004
22	Bites and Stings (Sting) 01/2021 - 01/2006
17	Visceral Leishmaniasis (Kala Azar) 10/2021 - 03/2006
12	Cutaneous Leishmaniasis 11/2022 - 10/2004
10	Inflammation (Inflammations) 10/2020 - 02/2003
8	Pemphigus (Pemphigus Vulgaris) 01/2022 - 12/2004
5	Skin Diseases (Skin Disease) 01/2022 - 06/2010
5	Autoimmune Diseases (Autoimmune Disease) 09/2016 - 06/2012
4	Vector Borne Diseases 01/2020 - 01/2006
4	Malaria 01/2018 - 08/2002
4	Chagas Disease (American Trypanosomiasis) 12/2017 - 12/2004
4	Hypersensitivity (Allergy) 01/2017 - 01/2006
3	Tick Bites 12/2021 - 10/2008
3	Parasitic Diseases (Parasitic Disease) 01/2018 - 10/2004
2	Erythema 12/2021 - 01/2020
2	Pain (Aches) 01/2020 - 04/2012
2	Edema (Dropsy) 01/2018 - 09/2012
2	Pemphigus and fogo selvagem 03/2016 - 08/2012
2	Experimental Arthritis 04/2012 - 10/2011
2	Hookworm Infections (Hookworm Infection) 01/2006 - 06/2005
1	Tick-Borne Diseases (Tick-Borne Disease) 12/2021
1	Pruritus (Itching) 01/2020
1	Exanthema (Rash) 01/2020
1	Mosquito-Borne Diseases 01/2020
1	Hemolysis 01/2020
1	Dengue (Dengue Fever) 12/2018
1	Hemorrhage 01/2018
1	Necrosis 01/2018
1	Virus Diseases (Viral Diseases) 01/2018
1	Tick Infestations 04/2017
1	Latent Infection 01/2017
1	Parasitemia 01/2017
1	Thromboinflammation 01/2016
1	Ulcer 12/2012
1	Thrombosis (Thrombus) 09/2012
1	Cardiomyopathies (Cardiomyopathy) 09/2012

Drug/Important Bio-Agent (IBA)

38	Salivary Proteins and PeptidesIBA 11/2022 - 10/2004
32	VaccinesIBA 12/2021 - 09/2002
18	AntigensIBA 12/2021 - 01/2006
18	Proteins (Proteins, Gene)FDA Link 12/2021 - 08/2002
8	AntibodiesIBA 01/2022 - 12/2004
7	Immunoglobulin G (IgG)IBA 11/2022 - 08/2012
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2015
5	AutoantibodiesIBA 01/2022 - 08/2012
5	Leishmaniasis VaccinesIBA 01/2022 - 05/2009
5	DNA (Deoxyribonucleic Acid)IBA 12/2021 - 08/2010
5	CytokinesIBA 01/2021 - 06/2005
5	Recombinant ProteinsIBA 01/2020 - 03/2010
5	Biological ProductsIBA 01/2017 - 09/2002
4	Desmoglein 1IBA 01/2022 - 08/2012
4	ChemokinesIBA 01/2021 - 08/2010
3	AutoantigensIBA 12/2020 - 03/2016
3	Peptides (Polypeptides)IBA 09/2014 - 08/2010
2	Messenger RNA (mRNA)IBA 12/2021 - 01/2021
2	glucopyranosyl lipid-AIBA 10/2021 - 01/2017
2	Combined VaccinesIBA 10/2021 - 11/2017
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2018
2	DesmogleinsIBA 12/2020 - 06/2010
2	Heme Oxygenase-1IBA 10/2020 - 01/2018
2	LipocalinsIBA 12/2017 - 02/2003
2	Complement System Proteins (Complement)IBA 01/2017 - 01/2016
2	Pharmaceutical PreparationsIBA 01/2017 - 01/2011
2	NucleosidesIBA 04/2015 - 10/2011
2	AnticoagulantsIBA 09/2012 - 05/2002
2	ProteomeIBA 01/2012 - 08/2010
1	VirosomesIBA 10/2021
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 01/2021
1	SNARE Proteins (SNAREs)IBA 01/2021
1	Interleukin-10 (Interleukin 10)IBA 01/2021
1	Vesicle-Associated Membrane Protein 2 (VAMP2)IBA 01/2021
1	Heme (Haem)IBA 10/2020
1	IronIBA 10/2020
1	IsoenzymesIBA 10/2020
1	Interleukin-5 (Interleukin 5)IBA 01/2019
1	InflammasomesIBA 01/2018
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2018
1	Apyrase (ATP Diphosphatase)IBA 01/2018
1	EndonucleasesIBA 01/2018
1	Interleukin-2 (IL2)IBA 01/2018
1	Interleukin-7 (Interleukin 7)IBA 01/2018
1	Interleukin-15 (Interleukin 15)IBA 01/2018
1	Interleukin-18 (Interleukin 18)IBA 01/2018
1	Cysteine Proteases (Cysteine Protease)IBA 01/2017
1	EmulsionsIBA 01/2017
1	Subunit VaccinesIBA 01/2017
1	ProperdinIBA 01/2016
1	Prostaglandins AIBA 01/2016
1	LectinsIBA 01/2016
1	beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA 04/2015
1	PotassiumIBA 09/2014
1	DNA VaccinesIBA 04/2014
1	EpitopesIBA 04/2014
1	amsonic acid (DAS)IBA 04/2014

Therapy/Procedure

1	Intradermal Injections 01/2021
1	Subcutaneous Injections 01/2020
1	Immunomodulation 09/2014
1	Therapeutics 09/2014
1	Injections 09/2012
1	Drug Therapy (Chemotherapy) 09/2012